CN Patent
CN101836959A — 一种制备几乎无苦味利福昔明干混悬剂的方法
Assigned to SHANDONG DAYIN MARINE BIOTECHNOLOGICAL PHARM HOLDINGS CO Ltd · Expires 2010-09-22 · 16y expired
What this patent protects
本发明提供了一种制备几乎无苦味利福昔明干混悬剂的方法,所述方法为将利福昔明通过20~35%乙醇溶液,之后在不高于60℃条件下干燥,干燥后筛至一定粒度,再与填充剂乳糖,助悬剂羟丙基甲基纤维素,调味剂阿司帕坦和香精混合,制备利福昔明干混悬剂。
USPTO Abstract
本发明提供了一种制备几乎无苦味利福昔明干混悬剂的方法,所述方法为将利福昔明通过20~35%乙醇溶液,之后在不高于60℃条件下干燥,干燥后筛至一定粒度,再与填充剂乳糖,助悬剂羟丙基甲基纤维素,调味剂阿司帕坦和香精混合,制备利福昔明干混悬剂。
Drugs covered by this patent
- Xifaxan (rifaximin) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.